Search

Search any products, services and so on here.

About 19662 result(s)

Hypothyroidism Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660587
  • Pages: 107
  • Figures: 177
  • Views: 6
  • From $3,950

Hypothyroidism is a condition characterized by an underactive thyroid gland, which leads to a decrease in the production of thyroid hormones. The primary treatment for hypothyroidism is hormone replacement therapy, typically in the form of synthetic thyroid hormones. The global market for Hypothyroidism Treatment was estimated to be worth US$ 3700 million in 2023 and is forecast to a readjusted...


OTC Veterinary Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660581
  • Pages: 106
  • Figures: 192
  • Views: 4
  • From $3,950

Over-the-counter (OTC) veterinary drugs are medications that can be purchased directly by pet owners without a prescription from a veterinarian. These medications are typically used for the treatment and management of minor health conditions in animals. The global market for OTC Veterinary Drug was estimated to be worth US$ 8421 million in 2023 and is forecast to a readjusted size of US$ 13890 mi...


Motion Sickness Pills - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660561
  • Pages: 85
  • Figures: 155
  • Views: 4
  • From $3,950

Motion sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness. The global market for Motion Sickness Pi...


Trastuzumab Monoclonal Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660560
  • Pages: 101
  • Figures: 202
  • Views: 4
  • From $3,950

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. The global market for Trastuzumab Monoclonal Antibody was estimated to be worth US$ 4512 million in 2023 and is forecast to a readjusted size of US$ 6303.7 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030 North American market for Trastuz...


Thyrogen and Biosimilar - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660558
  • Pages: 87
  • Figures: 190
  • Views: 4
  • From $3,950

THYROGEN (thyrotropin alfa for injection) contains recombinant human thyroid stimulating hormone (TSH). Thyrotropin alfa is synthesized in a genetically modified Chinese hamster ovary cell line. The global market for Thyrogen and Biosimilar was estimated to be worth US$ 257 million in 2023 and is forecast to a readjusted size of US$ 682.6 million by 2030 with a CAGR of 15.7% during the forecast p...


Orally Disintegrating Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660557
  • Pages: 114
  • Figures: 182
  • Views: 4
  • From $3,950

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallo...


Rituxan (Rituximab) and Biosimilar - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660555
  • Pages: 81
  • Figures: 189
  • Views: 5
  • From $3,950

RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin's Lymphoma (NHL) and mature B-cell acute leukemia (B-AL): in combination with chemotherapy medicines. The global market for Rituxan (Rituximab) and Biosimilar was estimated to be worth...


Rituxan (Rituximab) Monoclonal Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660554
  • Pages: 83
  • Figures: 191
  • Views: 4
  • From $3,950

RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin's Lymphoma (NHL) and mature B-cell acute leukemia (B-AL): in combination with chemotherapy medicines. The global market for Rituxan (Rituximab) Monoclonal Antibody was estimated to be...


Remicade (Infliximab) Monoclonal Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660553
  • Pages: 83
  • Figures: 189
  • Views: 4
  • From $3,950

Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. Avsola, Flixabi, Inflectra, Remicade, Renflexis. The global market for Remicade (Infliximab) Monoclonal Antibody was estimated to be worth US$ 2550 million in 2023 and is forecast to a rea...


Remicade (Infliximab) and Biosimilar - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Nov 05, 24
  • ID: 660552
  • Pages: 88
  • Figures: 188
  • Views: 4
  • From $3,950

Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. Avsola, Flixabi, Inflectra, Remicade, Renflexis. The global market for Remicade (Infliximab) and Biosimilar was estimated to be worth US$ 2550 million in 2023 and is forecast to a readjust...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232